Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections
- PMID: 25367298
- DOI: 10.1093/infdis/jiu607
Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections
Abstract
Background: Aspergillus and Mucorales species cause severe infections in patients after hematopoietic stem cell transplantation (HSCT). Induction of antifungal CD4(+) T-helper type 1 (Th1) immunity is an appealing strategy to combat these infections. Immunotherapeutic approaches are so far limited because of a lack of antigens inducing protective T cells, their elaborate production, and the need of targeting a broad spectrum of pathogenic fungi.
Methods: We examined the response to different Aspergillus fumigatus proteins in healthy individuals and patients after HSCT and compared rapid selection protocols for fungus-specific T cells based on CD137 or CD154 expression.
Results: The A. fumigatus proteins Crf1, Gel1, and Pmp20 induced strong Th1 responses in healthy individuals. T cells specific for these antigens expanded in patients with active invasive aspergillosis, indicating their contribution to infection control. Th1 cells specific for the 3 proteins can be selected with similar specificity within 24 hours, based on CD137 or CD154 expression. These cells recognize naturally processed A. fumigatus and the multispecific T-cell lines, directed against all 3 proteins, especially those selected by CD154, additionally cross-react to different Aspergillus and Mucorales species.
Conclusions: These findings may form the basis for adoptive T-cell transfer for prophylaxis or treatment in patients with these devastating infections.
Keywords: Aspergillus; CD137 and CD154 expression; T-cell therapy; fungal infection; multispecific T cells.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Characterization of the T-cell-mediated immune response against the Aspergillus fumigatus proteins Crf1 and catalase 1 in healthy individuals.J Infect Dis. 2013 Sep 1;208(5):847-56. doi: 10.1093/infdis/jit237. Epub 2013 May 22. J Infect Dis. 2013. PMID: 23698813
-
Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer.Cytotherapy. 2015 Oct;17(10):1396-405. doi: 10.1016/j.jcyt.2015.05.011. Epub 2015 Jul 15. Cytotherapy. 2015. PMID: 26188965
-
Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy.Bone Marrow Transplant. 2009 Jan;43(1):13-9. doi: 10.1038/bmt.2008.271. Epub 2008 Sep 1. Bone Marrow Transplant. 2009. PMID: 18762764
-
The Pathogenesis of Aspergillus fumigatus, Host Defense Mechanisms, and the Development of AFMP4 Antigen as a Vaccine.Pol J Microbiol. 2021 Mar;70(1):3-11. doi: 10.33073/pjm-2021-003. Epub 2021 Mar 9. Pol J Microbiol. 2021. PMID: 33815522 Free PMC article. Review.
-
Vaccination approaches against opportunistic fungal infections caused by Aspergillus fumigatus.Curr Protein Pept Sci. 2014;15(5):424-9. doi: 10.2174/1389203715666140512122037. Curr Protein Pept Sci. 2014. PMID: 24818757 Review.
Cited by
-
Aspergillus vaccines: Hardly worth studying or worthy of hard study?Med Mycol. 2017 Jan 1;55(1):103-108. doi: 10.1093/mmy/myw081. Epub 2016 Sep 17. Med Mycol. 2017. PMID: 27639242 Free PMC article. Review.
-
Immune responses to invasive aspergillosis: new understanding and therapeutic opportunities.Curr Opin Infect Dis. 2017 Aug;30(4):364-371. doi: 10.1097/QCO.0000000000000381. Curr Opin Infect Dis. 2017. PMID: 28509673 Free PMC article. Review.
-
Adoptive T-cell therapy for fungal infections in haematology patients.Clin Transl Immunology. 2015 Aug 14;4(8):e40. doi: 10.1038/cti.2015.16. eCollection 2015 Aug. Clin Transl Immunology. 2015. PMID: 26366286 Free PMC article. Review.
-
Unveiling signaling pathways inducing MHC class II expression in neutrophils.Front Immunol. 2024 Sep 30;15:1444558. doi: 10.3389/fimmu.2024.1444558. eCollection 2024. Front Immunol. 2024. PMID: 39403371 Free PMC article.
-
Immunomodulation as a Therapy for Aspergillus Infection: Current Status and Future Perspectives.J Fungi (Basel). 2018 Dec 14;4(4):137. doi: 10.3390/jof4040137. J Fungi (Basel). 2018. PMID: 30558125 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials